ARTICLE | Finance
Reasons unknown
All parties mum as Chimerix CEO departs with stock up through Josh Hardy storm
April 14, 2014 7:00 AM UTC
The real story behind the unexpected departure of Chimerix Inc. President and CEO Kenneth Moch 29 days after the company extricated itself from a public relations crisis will probably never be known. It certainly wasn't because of the stock's performance.
The stock climbed steadily even as the embattled company tried to explain its initial refusal to grant compassionate access to brincidofovir for Josh Hardy, a pediatric cancer patient...